Funding Opportunities & Notices Search Results
    

Related Links:                        
All Active Funding Opportunities (RFAs & PAs)

            

       Matching Records:  1274        Sorted by:  Issuing Organization then Release Date *

Announcement
Number
Related
Announc.

Issuing
Organization
*
Release
Date
Opening Date
(SF424 Only) Opening Date is the earliest date an electronic application may be submitted to Grants.gov - Applies only to SF424 electronic applications. Click on Question Mark for more information.
Expiration
Date
Activity
Code(s)
Title
PA-18-794 See Related AHRQ 05/21/2018 09/17/2018 07/06/2021 R03 AHRQ Small Research Grant Program (R03)
PA-18-793 See Related AHRQ 05/21/2018 08/24/2018 01/28/2021 R18 AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
PA-18-795 See Related AHRQ 05/21/2018 09/05/2018 07/06/2021 R01 AHRQ Health Services Research Projects (R01)
PA-18-792 See Related AHRQ 05/21/2018 08/28/2018 01/28/2020 U18 Advancing Evidence into Practice through Shared, Interoperable Clinical Decision Support Resources (U18)
PA-18-765 See Related AHRQ 05/02/2018 07/30/2018 05/02/2023 R36 AHRQ Health Services Research Dissertation Program (R36)
PA-18-750 See Related AHRQ 04/10/2018 09/25/2018 09/08/2021 R18 Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18)
PA-17-481 See Related AHRQ 09/12/2017 09/12/2017 08/09/2022 F32 Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32)
PA-17-246 See Related AHRQ 04/03/2017 04/17/2017 07/17/2020 R21 Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)
PA-17-247 See Related AHRQ 04/03/2017 04/17/2017 09/27/2020 U18 Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
PA-17-232 See Related AHRQ 03/29/2017 03/31/2017 07/13/2022 K08 AHRQ Mentored Clinical Scientist Research Career Development Award (K08)
PA-17-077 See Related AHRQ 12/12/2016 01/25/2017 01/26/2020 R18 Utilizing Health Information Technology to Scale and Spread Successful Practice Models Using Patient-reported Outcomes (R18)
PA-17-007 See Related AHRQ 10/13/2016 12/25/2016 01/26/2021 R18 Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
PA-17-008 See Related AHRQ 10/13/2016 01/05/2017 03/06/2021 R01 Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
PA-16-453 See Related AHRQ 09/29/2016 11/02/2016 11/02/2021 R13 AHRQ Conference Grant Programs (R13)
PA-16-424 See Related AHRQ 09/08/2016 01/05/2017 02/05/2022 R01 Developing Measures of Shared Decision Making (R01)
PA-16-423 See Related AHRQ 09/06/2016 11/01/2016 10/31/2021 R01 Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
PA-16-422 See Related AHRQ 09/06/2016 11/01/2016 10/31/2021 R18 Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18)
PA-16-421 See Related AHRQ 09/06/2016 12/25/2016 09/26/2019 R18 Advancing Patient Safety Implementation through Safe Medication Use Research (R18)
PA-16-223 See Related AHRQ 05/05/2016 09/12/2016 11/12/2019 K01 AHRQ Mentored Research Scientist Research Career Development Award (K01)
PAR-18-812 See Related CDC 05/30/2018 05/25/2018 11/18/2023 R01 Occupational Safety and Health Research (R01)
PAR-18-799 See Related CDC 05/24/2018 05/24/2018 11/18/2023 K01 K01 Mentored Research Scientist Development Award
PAR-18-797 See Related CDC 05/24/2018 05/24/2018 11/18/2023 R03 NIOSH Small Research Grant Program
PAR-15-303 See Related CDC 07/21/2015 n/a 10/21/2019 T42 Occupational Safety and Health Education and Research Centers (T42)
PAR-19-306 See Related FDA 06/26/2019 08/01/2019 10/12/2022 R13 FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
RFA-FD-19-028 See Related FDA 06/06/2019 06/05/2019 08/06/2019 U01 Drug Development Tools Research Grants (U01 Clinical Trial Not Allowed)
RFA-FD-20-002 See Related FDA 05/29/2019 06/01/2019 09/11/2020 UC2 Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
RFA-FD-19-022 See Related FDA 05/29/2019 05/29/2019 07/30/2019 U01 Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Implementing Alternative Methods to Expand the Reach across the Global Supply Chain (U01) - Clinical Trials Not Allowed
RFA-FD-19-027 See Related FDA 05/29/2019 05/29/2019 07/30/2019 U18 Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional
RFA-FD-19-029 See Related FDA 05/23/2019 05/28/2019 07/30/2019 U01 Rare Disease Clinical Outcome Assessment Consortium (U01 Clinical Trial Not Allowed)
RFA-FD-19-025 See Related FDA 05/16/2019 05/17/2019 07/18/2019 U01 Information Sharing System for State-Regulated Drug Compounding Activities (U01) Clinical Trial Not Allowed
RFA-FD-19-026 See Related FDA 05/09/2019 05/10/2019 07/11/2019 U01 Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U01) Clinical Trials Not Allowed
RFA-FD-19-023 See Related FDA 05/01/2019 05/10/2019 07/11/2019 U18 National Project to Support and Promote Consistent Implementation of the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption (U18)
PAR-19-216 See Related FDA 03/13/2019 03/14/2019 04/05/2021 U01 Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional
PAR-19-190 See Related FDA 02/22/2019 03/01/2019 04/06/2021 U01 Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional
PAR-19-017 See Related FDA 10/02/2018 10/15/2018 03/02/2020 U18 State and Territory Produce Safety Implementation Program Expansion for Entrance into Competition B of PAR-16-137 (U18)
PAR-18-827 See Related FDA 06/11/2018 06/27/2018 01/16/2021 R01 Minor Use Minor Species Development of Drugs (R01)
PAR-18-604 See Related FDA 01/29/2018 02/01/2018 09/02/2023 U18 Vet-LIRN Network Capacity-Building Projects
RFA-FD-18-001 See Related FDA 10/31/2017 11/06/2017 12/02/2021 U18 Flexible Funding Model - Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18)
PAR-16-099 See Related FDA 02/12/2016 03/01/2016 05/02/2020 U01 NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)
PAR-19-285 See Related FIC 05/14/2019 07/20/2019 08/21/2021 G11 Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
PAR-19-283 See Related FIC 05/14/2019 07/20/2019 08/21/2021 D43 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
PAR-19-284 See Related FIC 05/14/2019 07/20/2019 08/21/2021 D71 Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
PAR-19-244 See Related FIC 04/09/2019 05/04/2019 06/05/2021 R25 International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
PAR-19-243 See Related FIC 04/09/2019 05/04/2019 06/05/2021 D43 International Bioethics Research Training Program (D43 Clinical Trial Optional)
PAR-19-098 See Related FIC 12/11/2018 10/07/2019 11/05/2020 K43 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
PAR-19-059 See Related FIC 11/07/2018 11/13/2018 12/14/2019 R21 Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
PAR-19-051 See Related FIC 11/02/2018 11/04/2018 11/05/2020 K43 Emerging Global Leader Award (K43 Independent Clinical Trial Required)
PAR-18-901 See Related FIC 08/13/2018 10/13/2018 11/14/2020 D43 Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)(Clinical Trial Optional)
PAR-18-840 See Related FIC 06/26/2018 06/26/2018 07/26/2019 D43 Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
PAR-18-835 See Related FIC 06/19/2018 10/07/2018 11/07/2020 R01 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
PAR-18-836 See Related FIC 06/19/2018 10/07/2018 11/07/2020 R21 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
PAR-18-539 See Related FIC 12/21/2017 02/07/2018 03/07/2020 K01 International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed
PAR-18-540 See Related FIC 12/21/2017 02/07/2018 03/07/2020 K01 International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required
PAR-17-058 See Related FIC 11/17/2016 06/26/2017 07/26/2019 D71 Planning Grant for Global Infectious Disease Research Training Program (D71)
RFA-TR-19-014 See Related NCATS 06/12/2019 09/09/2019 10/10/2019 UG3/UH3 "Clinical Trials" on a Chip: Tissue Chips to Inform Clinical Trial Design and Implementation in Precision Medicine (UG3/UH3 - Clinical Trial Not Allowed)
RFA-TR-19-020 See Related NCATS 05/21/2019 07/01/2019 08/01/2019 U18 Drug Screening with Biofabricated 3-D Skin Disease Tissue Models (U18 Clinical Trial Not Allowed)
PAR-19-100 See Related NCATS 12/12/2018 02/08/2019 11/10/2021 R21 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)
PAR-19-099 See Related NCATS 12/12/2018 02/08/2019 11/10/2021 U01 Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)
PAR-18-952 See Related NCATS 10/04/2018 12/07/2018 10/26/2021 R03 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
PAR-18-953 See Related NCATS 10/04/2018 12/07/2018 10/26/2021 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-18-940 See Related NCATS 09/27/2018 12/25/2018 08/16/2021 U54 Clinical and Translational Science Award (U54 Clinical Trial Optional)
PAR-18-910 See Related NCATS 08/31/2018 04/03/2019 08/27/2021 U01 Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required)
PAR-18-909 See Related NCATS 08/31/2018 10/01/2018 03/05/2021 X02 Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed)
PAR-18-462 See Related NCATS 11/30/2017 02/16/2018 11/17/2020 U34 Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed)
PAR-18-332 See Related NCATS 10/20/2017 01/05/2018 11/06/2020 U01 Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)
PAR-17-465 See Related NCATS 08/21/2017 09/30/2017 09/08/2020 UH2 Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
PAR-17-035 See Related NCATS 10/27/2016 12/05/2016 09/06/2019 R43/R44 Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
PAR-17-036 See Related NCATS 10/27/2016 12/05/2016 09/06/2019 R41/R42 Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
RFA-AT-19-011 See Related NCCIH 04/26/2019 06/07/2019 07/09/2019 U24 "HEAL Initiative: Limited Competition: Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) to Reduce Opioid Prescribing (U24 Clinical Trial Not Allowed)"
RFA-AT-19-010 See Related NCCIH 04/17/2019 05/26/2019 01/25/2020 T90/R90 Limited Competition: Interdisciplinary Complementary and Integrative Health Clinical Research Training (T90/R90 Independent Clinical Trial Not Allowed)
PA-19-201 See Related NCCIH 02/28/2019 05/16/2019 05/08/2022 R21 Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
PA-19-200 See Related NCCIH 02/28/2019 05/05/2019 05/08/2022 R01 Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)
PA-19-031 See Related NCCIH 10/18/2018 03/01/2019 10/02/2021 Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp Clinical Trial Optional)
PAR-18-828 See Related NCCIH 06/13/2018 07/31/2018 11/05/2019 R33 NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
PAR-18-829 See Related NCCIH 06/13/2018 07/31/2018 11/05/2019 R61/R33 NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
PAR-18-697 See Related NCCIH 03/05/2018 05/07/2018 11/05/2019 U24 Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
PAR-18-696 See Related NCCIH 03/05/2018 05/07/2018 11/05/2019 UG3/UH3 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
PAR-18-662 See Related NCCIH 02/14/2018 05/01/2018 02/29/2020 UG3/UH3 Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
PAR-18-663 See Related NCCIH 02/14/2018 05/01/2018 02/29/2020 U24 Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 - Clinical Trial Required)
PAR-18-125 See Related NCCIH 11/30/2017 05/08/2018 11/05/2019 U01 NCCIH Natural Product Phase II Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-417 See Related NCCIH 11/29/2017 01/16/2018 09/08/2020 R34 Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 - Clinical Trials Required)
PAS-18-121 See Related NCCIH 11/28/2017 03/06/2018 01/06/2020 R41/R42 Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional)
PAS-18-120 See Related NCCIH 11/28/2017 03/06/2018 01/06/2020 R43/R44 Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional)
PAR-18-118 See Related NCCIH 11/02/2017 01/03/2018 03/01/2020 U01 NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-115 See Related NCCIH 11/02/2017 01/02/2018 06/29/2019 R33 Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required)
PAR-18-114 See Related NCCIH 11/02/2017 01/02/2018 06/29/2019 R61/R33 Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required)
PAR-18-113 See Related NCCIH 10/30/2017 12/26/2017 01/08/2020 P01 Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional)
PA-18-322 See Related NCCIH 10/13/2017 01/16/2018 01/08/2021 R21 Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
PA-18-323 See Related NCCIH 10/13/2017 01/05/2018 01/08/2021 R01 Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
PAR-19-291 See Related NCI 06/05/2019 09/18/2019 10/19/2019 R50 NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-19-290 See Related NCI 06/05/2019 09/18/2019 10/19/2019 R50 NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-19-287 See Related NCI 05/22/2019 06/15/2019 11/16/2021 U01 Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)
PAR-19-279 See Related NCI 05/13/2019 06/15/2019 11/16/2020 R01 Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)
PAR-19-280 See Related NCI 05/13/2019 06/15/2019 11/16/2020 R21 Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
PAR-19-277 See Related NCI 05/08/2019 05/08/2019 10/09/2021 R21 Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)
PAR-19-274 See Related NCI 05/08/2019 05/08/2019 05/08/2022 R01 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
PAR-19-275 See Related NCI 05/08/2019 05/16/2019 05/08/2022 R21 Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PAR-19-276 See Related NCI 05/08/2019 05/16/2019 05/08/2022 R03 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
PAR-19-264 See Related NCI 05/01/2019 06/10/2019 12/11/2021 R01 Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)
PAR-19-251 See Related NCI 04/12/2019 06/02/2019 11/09/2021 R01 Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)
PAR-19-252 See Related NCI 04/12/2019 06/02/2019 11/09/2021 R21 Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)
PAR-19-242 See Related NCI 04/08/2019 05/18/2019 06/18/2021 K12 Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
RFA-CA-19-047 See Related NCI 04/08/2019 07/09/2019 08/10/2019 R44 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
RFA-CA-19-039 See Related NCI 03/28/2019 05/11/2019 11/21/2019 U01 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
RFA-CA-19-040 See Related NCI 03/28/2019 05/11/2019 11/21/2019 U24 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
RFA-CA-19-041 See Related NCI 03/28/2019 05/11/2019 11/21/2019 U24 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
RFA-CA-19-035 See Related NCI 03/27/2019 05/28/2019 06/29/2019 R01 Optimizing the Management and Outcomes for Cancer Survivors Transitioning to Follow-up Care (R01 Clinical Trial Required)
RFA-CA-19-038 See Related NCI 03/27/2019 05/11/2019 11/21/2019 R21 ITCR: innovative algorithms (R21 Clinical Trial Optional)
RFA-CA-19-034 See Related NCI 03/13/2019 05/19/2019 10/19/2020 P20 Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)
PAR-19-199 See Related NCI 02/27/2019 05/10/2019 11/09/2021 R21 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
PAR-19-198 See Related NCI 02/27/2019 05/10/2019 11/09/2021 R01 Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
PAR-19-194 See Related NCI 02/22/2019 05/16/2019 05/08/2022 R21 Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)
PAR-19-193 See Related NCI 02/22/2019 05/05/2019 05/08/2022 R01 Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)
PAR-19-184 See Related NCI 02/05/2019 05/16/2019 05/08/2022 R21 Biology of Bladder Cancer (R21 Clinical Trial Optional)
PAR-19-183 See Related NCI 02/05/2019 05/05/2019 05/08/2022 R01 Biology of Bladder Cancer (R01 Clinical Trial Optional)
RFA-CA-19-032 See Related NCI 01/24/2019 07/01/2019 08/04/2020 R01 Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
RFA-CA-19-033 See Related NCI 01/11/2019 02/15/2019 01/04/2020 U01 Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)
PAR-19-149 See Related NCI 01/08/2019 01/16/2019 01/08/2022 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
PAR-19-150 See Related NCI 01/08/2019 01/16/2019 01/08/2022 R21 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
RFA-CA-19-026 See Related NCI 01/07/2019 02/07/2019 09/28/2019 P01 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)
RFA-CA-19-024 See Related NCI 01/07/2019 02/07/2019 09/28/2019 U01 Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
RFA-CA-19-023 See Related NCI 01/07/2019 02/07/2019 09/28/2019 R01 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
RFA-CA-19-027 See Related NCI 01/07/2019 02/07/2019 09/28/2019 P50 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
RFA-CA-19-025 See Related NCI 01/07/2019 02/07/2019 09/28/2019 U54 Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)
RFA-CA-19-028 See Related NCI 01/07/2019 02/07/2019 09/28/2019 U2C Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
RFA-CA-19-021 See Related NCI 01/07/2019 02/07/2019 09/28/2019 R21 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
RFA-CA-19-020 See Related NCI 01/07/2019 02/07/2019 09/28/2019 R33 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
RFA-CA-19-019 See Related NCI 01/07/2019 02/07/2019 09/28/2019 R21 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
RFA-CA-19-022 See Related NCI 01/07/2019 02/07/2019 09/28/2019 R33 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
PA-19-112 See Related NCI 12/17/2018 01/05/2019 01/08/2022 R01 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)
PA-19-111 See Related NCI 12/17/2018 01/16/2019 01/08/2022 R21 Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)
PAR-19-113 See Related NCI 12/17/2018 01/05/2019 01/08/2022 R01 Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
PAR-19-101 See Related NCI 12/12/2018 12/30/2018 07/31/2020 U01 Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
PA-19-029 See Related NCI 10/17/2018 10/19/2018 02/03/2021 Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
PAR-18-947 See Related NCI 09/28/2018 10/28/2018 07/12/2021 U01 Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
PAR-18-919 See Related NCI 09/12/2018 01/05/2019 05/08/2020 R01 Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional)
PAR-18-913 See Related NCI 09/07/2018 01/11/2019 08/12/2021 U01 Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
PAR-18-911 See Related NCI 09/05/2018 10/14/2018 11/14/2020 P20 Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
PA-18-902 See Related NCI 08/14/2018 09/05/2018 09/08/2021 R01 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
PAR-18-892 See Related NCI 08/07/2018 09/16/2018 09/08/2021 R21 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
PAR-18-893 See Related NCI 08/07/2018 09/05/2018 09/08/2021 R01 Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
PAR-18-869 See Related NCI 07/24/2018 10/07/2018 03/09/2021 R01 Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
PA-18-842 See Related NCI 06/28/2018 08/10/2018 09/11/2020 Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
PAR-18-841 See Related NCI 06/28/2018 10/19/2018 06/15/2021 U24 Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)
PAR-18-802 See Related NCI 05/24/2018 08/05/2018 01/06/2021 R41/R42 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)
PAR-18-801 See Related NCI 05/24/2018 08/05/2018 01/06/2021 R43/R44 Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
PAR-18-767 See Related NCI 04/30/2018 12/09/2018 01/10/2020 U54 Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)
PA-18-738 See Related NCI 04/03/2018 05/05/2018 05/08/2021 R01 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).
PA-18-739 See Related NCI 04/03/2018 05/16/2018 05/08/2021 R21 Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).
PAR-18-731 See Related NCI 03/29/2018 05/19/2018 11/20/2020 R21 Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
PAR-18-681 See Related NCI 02/27/2018 03/11/2018 10/12/2019 R01 Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)
PA-18-678 See Related NCI 02/23/2018 05/16/2018 05/08/2021 R21 Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)
PA-18-677 See Related NCI 02/23/2018 05/05/2018 05/08/2021 R01 Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
PAR-18-674 See Related NCI 02/21/2018 05/13/2018 06/16/2020 R21 U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional)
PAR-18-675 See Related NCI 02/21/2018 05/13/2018 06/16/2020 R01 U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional)
PAR-18-655 See Related NCI 02/13/2018 05/19/2018 11/20/2020 R21 Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
PAR-18-654 See Related NCI 02/13/2018 05/19/2018 11/20/2020 R01 Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
PAR-18-641 See Related NCI 02/07/2018 04/30/2018 09/27/2019 R21 Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)
PAR-18-640 See Related NCI 02/07/2018 04/30/2018 09/27/2019 R01 Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)
PA-18-629 See Related NCI 02/05/2018 05/05/2018 05/08/2021 R01 Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
PAR-18-616 See Related NCI 02/01/2018 05/05/2018 07/06/2019 U01 Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)
PAR-18-560 See Related NCI 01/05/2018 02/15/2018 01/08/2021 R01 National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)
PAR-18-559 See Related NCI 01/05/2018 02/15/2018 01/08/2021 R01 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
PAR-18-530 See Related NCI 12/21/2017 02/28/2001 01/08/2021 R01 Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
PA-18-531 See Related NCI 12/20/2017 01/16/2018 01/08/2021 R03 Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
PA-18-532 See Related NCI 12/20/2017 01/16/2018 01/08/2021 R21 Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
PA-18-529 See Related NCI 12/20/2017 01/05/2018 01/08/2021 R01 Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
PA-18-493 See Related NCI 12/11/2017 05/05/2018 05/08/2021 R01 Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)
PA-18-492 See Related NCI 12/11/2017 05/16/2018 05/08/2021 R21 Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)
PAR-18-466 See Related NCI 12/06/2017 01/12/2018 03/13/2021 K22 The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)
PAR-18-467 See Related NCI 12/06/2017 01/12/2018 03/13/2021 K22 The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
PAR-18-476 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
PAR-18-477 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Courses for Skills Development (R25)
PAR-18-478 See Related NCI 12/05/2017 12/25/2017 01/08/2021 R25 Cancer Research Education Grants Program - Research Experiences (R25)
PAR-18-248 See Related NCI 11/29/2017 04/09/2018 01/10/2020 UG3/UH3 Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional)
PAR-18-023 See Related NCI 11/28/2017 03/05/2018 01/08/2020 R01 Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional)
PAR-18-022 See Related NCI 11/28/2017 03/04/2018 01/08/2020 R21 Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional)
PAR-18-021 See Related NCI 11/21/2017 01/28/2018 01/08/2020 R03 NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)
PAR-18-366 See Related NCI 11/20/2017 01/12/2018 01/08/2021 K22 NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)
PAR-18-367 See Related NCI 11/20/2017 01/12/2018 01/08/2021 K22 NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
PAR-18-364 See Related NCI 11/17/2017 01/12/2018 01/08/2021 K01 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed)
PAR-18-365 See Related NCI 11/17/2017 01/12/2018 01/08/2021 K01 NCI Mentored Research Scientist Development Award to Promote Diversity (Parent K01 - Clinical Trial Required)
PAR-18-019 See Related NCI 11/08/2017 01/17/2018 07/17/2019 R21 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
PAR-18-008 See Related NCI 11/08/2017 01/06/2018 07/06/2019 R01 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
PAR-18-011 See Related NCI 11/06/2017 01/15/2018 02/15/2020 R01 Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required)
PA-18-015 See Related NCI 11/03/2017 01/17/2018 01/08/2020 R21 Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional)
PA-18-014 See Related NCI 11/03/2017 01/17/2018 01/08/2020 R21 Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional)
PA-18-005 See Related NCI 11/03/2017 01/06/2018 01/08/2020 R01 Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional)
PA-18-004 See Related NCI 11/03/2017 01/06/2018 01/08/2020 R01 Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)
PAR-18-009 See Related NCI 11/01/2017 01/06/2018 11/06/2019 R01 Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)
PAR-18-337 See Related NCI 10/31/2017 01/12/2018 01/08/2021 K08 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)
PAR-18-336 See Related NCI 10/31/2017 01/12/2018 01/08/2021 K08 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)
PAR-18-290 See Related NCI 10/30/2017 12/26/2017 01/08/2020 P01 National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)
PAR-18-317 See Related NCI 10/12/2017 01/14/2018 10/09/2020 UH2/UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
PAR-18-310 See Related NCI 10/12/2017 01/14/2018 10/09/2020 UH3 Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed
PAR-18-313 See Related NCI 10/12/2017 12/25/2017 01/08/2021 P50 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
PAR-18-303 See Related NCI 10/03/2017 03/05/2018 01/08/2021 R43/R44 Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)
PAR-17-496 See Related NCI 09/29/2017 04/14/2018 05/15/2020 R01 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
PAR-17-464 See Related NCI 09/29/2017 04/14/2018 05/15/2020 R21 Research to Improve Native American Health (R21 Clinical Trial Optional)
PA-17-495 See Related NCI 09/29/2017 01/05/2018 01/08/2021 R01 Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)
PA-17-460 See Related NCI 08/16/2017 01/16/2018 01/08/2021 R01 Biology of Lung, and Head and Neck Preneoplasias (R21 - Clinical Trial Not Allowed)
PA-17-459 See Related NCI 08/15/2017 01/05/2018 01/08/2021 R01 Biology of Lung, and Head and Neck Preneoplasias (R01)
PA-17-449 See Related NCI 08/04/2017 09/16/2017 09/08/2020 R21 The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
PA-17-440 See Related NCI 08/04/2017 09/05/2017 09/08/2020 R01 The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
PAR-17-438 See Related NCI 07/27/2017 09/05/2017 09/08/2020 R01 Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
PA-17-330 See Related NCI 07/21/2017 09/05/2017 09/08/2020 R01 Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
PAR-17-331 See Related NCI 07/20/2017 09/05/2017 09/08/2020 R01 Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
PA-17-298 See Related NCI 06/22/2017 09/05/2017 09/08/2020 R01 Integration of Individual Residential Histories into Cancer Research (R01)
PA-17-295 See Related NCI 06/22/2017 09/16/2017 09/08/2020 R21 Integration of Individual Residential Histories into Cancer Research (R21)
PA-17-289 See Related NCI 05/16/2017 09/05/2017 09/08/2020 R01 Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)
PA-17-288 See Related NCI 05/16/2017 09/16/2017 09/08/2020 R21 Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)
PAR-17-244 See Related NCI 04/04/2017 05/05/2017 05/08/2020 R01 Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)
PAR-17-245 See Related NCI 04/03/2017 05/05/2017 05/08/2020 R01 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)
PA-17-239 See Related NCI 03/30/2017 05/05/2017 05/08/2020 R01 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
PA-17-243 See Related NCI 03/30/2017 05/16/2017 05/08/2020 R21 Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
PAR-17-240 See Related NCI 03/30/2017 10/21/2017 05/22/2020 R01 Innovative Research in Cancer Nanotechnology (IRCN) (R01)
PAR-17-233 See Related NCI 03/29/2017 05/05/2017 05/08/2020 U01 Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01)
PAR-17-204 See Related NCI 03/07/2017 07/16/2017 01/16/2020 R21 Inter-organelle Communication in Cancer (R21)
PAR-17-203 See Related NCI 03/07/2017 07/16/2017 01/16/2020 R01 Inter-organelle Communication in Cancer (R01)
PAR-17-095 See Related NCI 12/21/2016 12/25/2016 01/08/2020 P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
PAR-17-059 See Related NCI 11/25/2016 12/25/2016 09/26/2019 R25 National Cancer Institute Youth Enjoy Science Research Education Program (R25)
PAR-17-003 See Related NCI 10/04/2016 01/28/2017 10/29/2019 R01 Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)
PA-16-425 See Related NCI 09/07/2016 12/07/2016 09/08/2019 R21 "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
PA-16-426 See Related NCI 09/07/2016 12/07/2016 09/08/2019 R01 "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)
PAR-16-337 See Related NCI 06/16/2016 09/16/2016 07/17/2019 R03 Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03)
PA-16-258 See Related NCI 05/16/2016 09/16/2016 09/08/2019 R21 Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
PAR-16-246 See Related NCI 05/09/2016 09/26/2016 06/28/2019 R21 Neural Regulation of Cancer (R21)
PAR-16-245 See Related NCI 05/09/2016 09/26/2016 06/28/2019 R01 Neural Regulation of Cancer (R01)
PAR-16-228 See Related NCI 05/06/2016 09/05/2016 09/08/2019 R01 Metabolic Reprogramming to Improve Immunotherapy (R01)
PAR-16-229 See Related NCI 05/06/2016 09/16/2016 09/08/2019 R21 Metabolic Reprogramming to Improve Immunotherapy (R21)
PAR-16-226 See Related NCI 05/05/2016 09/16/2016 09/08/2019 R21 The Role of Mobile Genetic Elements in Cancer (R21)
PAR-16-227 See Related NCI 05/05/2016 09/05/2016 09/08/2019 R01 The Role of Mobile Genetic Elements in Cancer (R01)
PA-16-177 See Related NCI 04/08/2016 09/16/2016 07/17/2019 R21 Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)
PAR-19-260 See Related NEI 04/24/2019 05/16/2019 05/08/2022 R21 NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
PAR-19-231 See Related NEI 03/29/2019 05/16/2019 05/08/2022 R34 NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
PAR-18-912 See Related NEI 09/07/2018 10/08/2018 11/10/2020 R01 U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
PAR-18-864 See Related NEI 07/19/2018 08/25/2018 09/08/2021 UG1 NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
PAR-18-726 See Related NEI 03/28/2018 05/11/2018 06/12/2020 K12 NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
PAR-18-707 See Related NEI 03/06/2018 03/10/2018 04/10/2020 R24 NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
RFA-EY-18-001 See Related NEI 03/02/2018 04/01/2018 10/30/2020 R21 BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
PAR-18-523 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required)
PAR-18-522 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required)
PAR-18-521 See Related NEI 12/20/2017 12/25/2017 01/08/2021 UG1 NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
PA-18-500 See Related NEI 12/15/2017 01/16/2018 01/08/2021 R21 Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)
PA-18-351 See Related NEI 11/08/2017 01/05/2018 01/08/2021 R01 Human Subjects Mechanistic and Minimal Risk Studies (R01 Clinical Trial Optional)
PAR-17-322 See Related NEI 06/23/2017 08/28/2017 09/19/2019 P30 NEI Center Core Grant for Vision Research (P30)
RFA-HG-19-013 See Related NHGRI 05/23/2019 07/02/2019 08/03/2019 U01 The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Clinical Sites (U01 Clinical Trial Required)
RFA-HG-19-014 See Related NHGRI 05/23/2019 07/02/2019 08/03/2019 U01 The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Enhanced Diversity Clinical Sites (U01 Clinical Trial Required)
RFA-HG-19-015 See Related NHGRI 05/23/2019 07/02/2019 08/03/2019 U01 The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required)
RFA-HG-19-012 See Related NHGRI 03/27/2019 06/23/2019 07/24/2019 RM1 Limited Competition Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEER) (RM1 Clinical Trial Optional)
PAR-19-204 See Related NHGRI 02/28/2019 04/20/2019 05/21/2021 RM1 Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional)
PAR-19-185 See Related NHGRI 02/12/2019 04/25/2019 01/26/2022 R25 Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed)
PAR-19-061 See Related NHGRI 11/08/2018 12/05/2018 09/06/2021 R43/R44 Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed)
PA-19-043 See Related NHGRI 10/31/2018 12/05/2018 09/06/2021 R43/R44 Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed)
RFA-HG-18-006 See Related NHGRI 07/31/2018 09/30/2018 10/21/2020 R35 Genomic Innovator Award (R35 Clinical Trial Optional)
PA-18-867 See Related NHGRI 07/23/2018 09/16/2018 07/17/2021 R21 Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
PA-18-868 See Related NHGRI 07/23/2018 09/05/2018 07/06/2021 R01 Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
PAR-18-844 See Related NHGRI 06/28/2018 10/16/2018 09/08/2021 R01 Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
PAR-18-843 See Related NHGRI 06/28/2018 10/16/2018 09/08/2021 R21 Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
PAR-18-777 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R01 Novel Genomic Technology Development (R01 Clinical Trial Not Allowed)
PAR-18-779 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R43/R44 Novel Genomic Technology Development (R43/R44 Clinical Trial Not Allowed)
PAR-18-778 See Related NHGRI 05/09/2018 09/02/2018 01/08/2021 R21 Novel Genomic Technology Development (R21 Clinical Trial Not Allowed)
RFA-HG-18-002 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R21 Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
RFA-HG-18-001 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R01 Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
RFA-HG-18-003 See Related NHGRI 04/18/2018 05/27/2018 09/11/2020 R43/R44 Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)
PAR-18-735 See Related NHGRI 04/02/2018 05/21/2018 01/23/2021 R01 Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)
PAR-18-736 See Related NHGRI 04/02/2018 05/21/2018 01/23/2021 R21 Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
PAR-17-482 See Related NHGRI 09/13/2017 01/05/2018 01/08/2021 R01 Comparative Genomics Research Program (R01)
PA-17-444 See Related NHGRI 08/01/2017 09/05/2017 09/08/2020 R01 Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
PA-17-445 See Related NHGRI 08/01/2017 09/16/2017 09/08/2020 R03 Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
PA-17-446 See Related NHGRI 08/01/2017 09/16/2017 09/08/2020 R21 Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
PAR-17-273 See Related NHGRI 05/08/2017 06/13/2017 01/26/2020 U24 Genomic Community Resources (U24)
PAR-17-269 See Related NHGRI 05/03/2017 05/17/2017 07/11/2020 X01 Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
PA-16-435 See Related NHGRI 09/19/2016 04/07/2017 05/08/2020 R01 Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
PAR-16-275 See Related NHGRI 05/19/2016 09/04/2016 09/08/2019 R01 Serious Adverse Drug Reaction Research (R01)
PAR-16-274 See Related NHGRI 05/19/2016 09/04/2016 09/08/2019 R21 Serious Adverse Drug Reaction Research (R21)
RFA-HL-20-015 See Related NHLBI 06/06/2019 09/02/2019 10/03/2019 U01 Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)
RFA-HL-20-017 See Related NHLBI 06/06/2019 09/02/2019 10/03/2019 U01 Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)
RFA-HL-20-007 See Related NHLBI 06/04/2019 09/01/2019 10/02/2019 U01 Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial Not Allowed)
RFA-HL-20-005 See Related NHLBI 04/11/2019 06/08/2019 07/09/2019 UG3/UH3 Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)
RFA-HL-20-014 See Related NHLBI 04/04/2019 05/18/2019 06/18/2020 UG3/UH3 Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)
RFA-HL-20-004 See Related NHLBI 03/11/2019 04/17/2019 12/03/2019 U24 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
RFA-HL-20-003 See Related NHLBI 03/11/2019 04/17/2019 12/03/2019 UG3/UH3 Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
RFA-HL-20-012 See Related NHLBI 01/25/2019 02/14/2019 04/16/2021 R35 NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
RFA-HL-20-011 See Related NHLBI 01/25/2019 02/14/2019 04/16/2021 R35 NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
PA-19-166 See Related NHLBI 01/22/2019 05/05/2019 05/08/2022 R01 Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional)
PAR-19-155 See Related NHLBI 01/08/2019 01/16/2019 01/08/2021 R34 NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
RFA-HL-20-002 See Related NHLBI 12/03/2018 02/01/2019 05/09/2020 K99/R00 Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Required)
RFA-HL-20-001 See Related NHLBI 12/03/2018 02/01/2019 05/09/2020 K99/R00 Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed)
PA-19-049 See Related NHLBI 11/01/2018 01/16/2019 01/08/2022 R21 New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed)
PAR-19-048 See Related NHLBI 11/01/2018 09/18/2019 10/19/2019 X01 NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
RFA-HL-19-025 See Related NHLBI 07/19/2018 09/10/2018 05/07/2021 K01 Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
RFA-HL-19-026 See Related NHLBI 07/19/2018 09/10/2018 05/07/2021 K01 Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
RFA-HL-19-017 See Related NHLBI 05/16/2018 06/27/2018 07/10/2020 R44 NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)
RFA-HL-19-018 See Related NHLBI 05/16/2018 06/27/2018 07/10/2020 R44 NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
PA-18-784 See Related NHLBI 05/15/2018 09/05/2018 09/08/2021 R01 The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed)
PAR-18-771 See Related NHLBI 05/09/2018 05/12/2018 01/08/2021 K22 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
PAR-18-772 See Related NHLBI 05/09/2018 05/12/2018 01/08/2021 K22 NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
RFA-HL-19-024 See Related NHLBI 05/01/2018 08/10/2018 05/07/2021 R25 Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)
RFA-HL-19-023 See Related NHLBI 04/27/2018 08/04/2018 05/07/2021 T32 T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
RFA-HL-19-015 See Related NHLBI 03/30/2018 05/04/2018 09/11/2020 R01 Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)
RFA-HL-19-016 See Related NHLBI 03/15/2018 05/11/2018 09/11/2020 R43 Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed)
RFA-HL-19-014 See Related NHLBI 03/05/2018 05/14/2018 06/16/2020 R01 Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed)
PAR-18-683 See Related NHLBI 02/27/2018 05/04/2018 01/08/2021 R61/R33 NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
PAR-18-684 See Related NHLBI 02/27/2018 05/04/2018 01/08/2021 R33 NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
PAR-18-643 See Related NHLBI 02/08/2018 03/30/2018 12/19/2020 R01 NHLBI Clinical Ancillary Studies (R01 - Clinical Trial Optional)
PAR-18-577 See Related NHLBI 01/12/2018 05/05/2018 06/06/2020 U01 New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed)
PAR-18-463 See Related NHLBI 12/01/2017 01/16/2018 01/08/2021 R34 NHLBI Clinical Trial Pilot Studies (R34 - Clinical Trial Optional)
PAR-18-132 See Related NHLBI 11/08/2017 01/17/2018 01/08/2020 R21 Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional)
PAR-18-126 See Related NHLBI 11/08/2017 01/06/2018 01/08/2020 R01 Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional)
PAR-18-406 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 R61/R33 Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
PAR-18-407 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 UG3/UH3 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3) - Clinical Trial Required
PAR-18-410 See Related NHLBI 10/25/2017 01/13/2018 09/14/2019 U24 Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
PAR-18-405 See Related NHLBI 10/20/2017 12/25/2017 01/08/2021 P01 NHLBI Program Project Applications (P01 - Clinical Trials Optional)
RFA-HL-18-023 See Related NHLBI 08/23/2017 09/24/2017 05/13/2020 R38 Stimulating Access to Research in Residency (StARR) (R38)
PAR-17-338 See Related NHLBI 08/21/2017 01/22/2018 02/21/2020 U01 Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)
PAR-17-004 See Related NHLBI 10/06/2016 01/24/2017 10/31/2019 R21 Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
RFA-HL-17-022 See Related NHLBI 08/29/2016 01/16/2017 01/08/2020 R21 Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
RFA-AG-20-041 See Related NIA 06/26/2019 09/23/2019 10/24/2019 R21 Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R21 Clinical Trial Not Allowed)
RFA-AG-20-042 See Related NIA 06/26/2019 09/23/2019 10/24/2019 R01 Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed)
PAR-19-304 See Related NIA 06/25/2019 09/16/2019 07/17/2022 R33 Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)
PAR-19-305 See Related NIA 06/25/2019 09/16/2019 07/17/2022 R21/R33 Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)
RFA-AG-20-028 See Related NIA 06/25/2019 09/22/2019 10/23/2019 R61/R33 Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)
RFA-AG-20-018 See Related NIA 06/25/2019 09/02/2019 10/03/2019 R03 Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
PAR-19-302 See Related NIA 06/24/2019 09/05/2019 09/08/2022 R01 NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
RFA-AG-20-039 See Related NIA 06/24/2019 01/03/2020 02/04/2020 R01 Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed)
RFA-AG-20-007 See Related NIA 06/14/2019 09/22/2019 10/23/2019 U34 Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)
PAR-19-298 See Related NIA 06/14/2019 09/05/2019 09/08/2022 R01 Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)
RFA-AG-20-022 See Related NIA 06/11/2019 09/22/2019 10/23/2019 R01 Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional)
RFA-AG-20-019 See Related NIA 06/05/2019 09/02/2019 10/03/2019 P30 Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
RFA-AG-20-006 See Related NIA 06/05/2019 09/23/2019 10/24/2019 R01 Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional)
RFA-AG-20-036 See Related NIA 06/05/2019 12/29/2019 01/30/2020 R01 Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed)
RFA-AG-20-023 See Related NIA 05/30/2019 09/09/2019 10/10/2019 P20 Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed)
RFA-AG-20-040 See Related NIA 05/30/2019 09/23/2019 10/24/2019 R01 Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
RFA-AG-20-025 See Related NIA 05/23/2019 09/17/2019 10/18/2019 R01 Understanding Senescence in Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
PAR-19-288 See Related NIA 05/23/2019 08/25/2019 09/26/2022 U54 Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed)
RFA-AG-20-043 See Related NIA 05/22/2019 06/22/2019 07/23/2019 U24 SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging (U24 Clinical Trials Not Allowed)
RFA-AG-20-029 See Related NIA 05/09/2019 01/03/2020 02/04/2020 R61/R33 Pragmatic Trials of Managing Multimorbidity in Alzheimer's Disease (R61/R33 Clinical Trial Required)
RFA-AG-20-008 See Related NIA 05/09/2019 06/22/2019 07/23/2019 T35 Summer Research Training in Aging for Medical Students (T35 Clinical Trial Not Allowed)
RFA-AG-20-017 See Related NIA 05/06/2019 01/03/2020 02/04/2020 R21/R33 Lucidity in Dementia (R21/R33 Clinical Trial Optional)
RFA-AG-20-016 See Related NIA 05/06/2019 01/03/2020 02/04/2020 R21 Lucidity in Dementia (R21 Clinical Trial Optional)
PAR-19-269 See Related NIA 05/06/2019 09/05/2019 09/08/2022 U01 Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed)
PAR-19-249 See Related NIA 04/12/2019 06/08/2019 03/09/2021 R01 Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed)
PAR-19-234 See Related NIA 04/02/2019 05/05/2019 05/08/2022 U01 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed)
PA-19-230 See Related NIA 03/28/2019 05/05/2019 07/06/2022 U01 Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required)
RFA-AG-20-013 See Related NIA 03/05/2019 06/02/2019 07/03/2019 R01 Geroscience Approaches to Alzheimer's Disease (R01 Clinical Trial Not Allowed)
RFA-AG-20-014 See Related NIA 03/05/2019 06/02/2019 07/03/2019 R21 Geroscience Approaches to Alzheimer's Disease (R21 Clinical Trial Not Allowed)
PAR-19-070 See Related NIA 11/16/2018 02/11/2019 11/13/2021 R01 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
PAR-19-071 See Related NIA 11/16/2018 02/11/2019 11/13/2021 R21 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
PAR-18-890 See Related NIA 08/03/2018 09/05/2018 09/08/2021 U01 Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)
PAR-18-889 See Related NIA 08/03/2018 09/05/2018 09/08/2021 U01 Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)
PAR-18-878 See Related NIA 07/26/2018 09/05/2018 09/08/2021 R01 Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required)
PAR-18-877 See Related NIA 07/26/2018 09/05/2018 09/08/2021 R01 Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional)
PA-18-825 See Related NIA 06/08/2018 09/05/2018 09/08/2021 R01 Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed)
PA-18-826 See Related NIA 06/08/2018 09/16/2018 09/08/2021 R21 Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 - Clinical Trial Not Allowed)
PA-18-824 See Related NIA 06/08/2018 09/16/2018 09/08/2021 R21 Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 - Clinical Trial Not Allowed)
PA-18-823 See Related NIA 06/08/2018 09/05/2018 09/08/2021 R01 Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed)
PAR-18-820 See Related NIA 06/07/2018 09/05/2018 09/08/2021 U01 Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
PAR-18-760 See Related NIA 04/18/2018 05/16/2018 01/08/2021 R21 In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
PAR-18-749 See Related NIA 04/10/2018 08/25/2018 01/26/2021 R24 Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed)
PAR-18-715 See Related NIA 03/21/2018 05/05/2018 05/08/2021 U01 NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed)
PAR-18-706 See Related NIA 03/06/2018 05/05/2018 11/06/2019 R01 Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
PAR-18-644 See Related NIA 02/08/2018 02/16/2018 09/08/2019 R33 Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)
PAR-18-645 See Related NIA 02/08/2018 02/16/2018 09/08/2019 R21/R33 Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
PAR-18-587 See Related NIA 01/26/2018 03/10/2018 01/09/2020 R41/R42 Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R41/R42 - Clinical Trials Optional)
PAR-18-588 See Related NIA 01/26/2018 03/10/2018 01/09/2020 R43/R44 Assistive Technology for Persons with Alzheimer's Disease and Related Dementias and Their Caregivers (R43/R44 - Clinical Trial Optional)
PAR-18-585 See Related NIA 01/24/2018 02/23/2018 02/21/2020 R61/R33 Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 - Clinical Trial Required)
PAR-18-582 See Related NIA 01/12/2018 02/27/2018 06/23/2020 R21 Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed)
PAR-18-581 See Related NIA 01/12/2018 02/27/2018 06/09/2020 R01 Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional)
PA-18-571 See Related NIA 01/11/2018 05/16/2018 05/08/2021 R03 Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional)
PA-18-570 See Related NIA 01/11/2018 05/05/2018 05/08/2021 R01 Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional)
PA-18-572 See Related NIA 01/11/2018 05/16/2018 05/08/2021 R21 Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional)
PAR-18-538 See Related NIA 12/21/2017 02/27/2018 06/23/2020 R21 Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
PAR-18-544 See Related NIA 12/21/2017 02/27/2018 06/09/2020 R01 Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
PAR-18-524 See Related NIA 12/21/2017 02/27/2018 01/08/2021 T32 Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)
PAR-18-514 See Related NIA 12/20/2017 03/05/2018 01/06/2021 R41/R42 Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
PAR-18-512 See Related NIA 12/20/2017 03/05/2018 01/06/2021 R43/R44 Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimers Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
PAR-18-519 See Related NIA 12/20/2017 02/23/2018 11/07/2020 R01 Sensory and motor system changes as predictors of preclinical Alzheimers disease (R01 - Clinical Trial Not Allowed)
PAR-18-516 See Related NIA 12/19/2017 02/27/2018 11/08/2020 R01 Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
PAR-18-513 See Related NIA 12/18/2017 02/27/2018 01/08/2021 R01 Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
PA-18-503 See Related NIA 12/15/2017 01/16/2018 05/08/2020 R21 Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)
PA-18-502 See Related NIA 12/15/2017 01/05/2018 05/08/2020 R01 Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)
PAR-18-497 See Related NIA 12/15/2017 02/23/2018 11/07/2020 R01 Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed)
PAR-18-190 See Related NIA 11/29/2017 04/07/2018 09/08/2020 R21 Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
PAR-18-189 See Related NIA 11/29/2017 04/07/2018 09/08/2020 R01 Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
PAS-18-188 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R41/R42 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
PAS-18-187 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
PAR-18-186 See Related NIA 11/28/2017 03/06/2018 04/06/2020 R43/R44 Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional)
PAR-18-185 See Related NIA 11/28/2017 03/06/2018 04/06/2020 R41/R42 Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)
PAR-18-184 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
PAR-18-183 See Related NIA 11/28/2017 03/06/2018 09/06/2019 R43/R44 T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)
PAR-18-297 See Related NIA 11/01/2017 12/26/2017 09/10/2019 P01 NIA Program Project Applications (P01 Clinical Trial Optional)
PAR-18-296 See Related NIA 11/01/2017 12/26/2017 09/08/2019 U19 Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
PAR-18-181 See Related NIA 11/01/2017 01/17/2018 01/08/2020 R21/R33 Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)
PAS-18-030 See Related NIA 11/01/2017 01/06/2018 01/08/2020 R01 Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
PA-18-025 See Related NIA 11/01/2017 01/06/2018 05/08/2020 R01 Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional)
PAR-18-030 See Related NIA 10/30/2017 12/26/2017 01/08/2020 P01 NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional)
PAR-18-029 See Related NIA 10/30/2017 01/06/2018 01/08/2020 R01 Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)
PAR-18-329 See Related NIA 10/25/2017 12/05/2017 01/06/2020 R43/R44 Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R43/R44 Clinical Trial Not Allowed)
PAR-18-326 See Related NIA 10/25/2017 12/05/2017 01/06/2020 R41/R42 Technology to Detect, Monitor and Assess Daily Functions in Individuals with Cognitive Decline, Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD) (R41/R42 Clinical Trial Not Allowed)
PAR-17-290 See Related NIA 05/16/2017 08/25/2017 09/08/2020 R25 NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25)
PAR-17-287 See Related NIA 05/15/2017 09/12/2017 09/08/2020 K07 NIA Academic Leadership Career Award (K07)
PAR-17-214 See Related NIA 03/10/2017 05/05/2017 05/08/2020 U01 Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)
PAR-17-127 See Related NIA 01/18/2017 05/16/2017 03/17/2020 R03 Juvenile Protective Factors and Their Effects on Aging (R03)
PAR-17-126 See Related NIA 01/18/2017 05/05/2017 03/06/2020 R01 Juvenile Protective Factors and Their Effects on Aging (R01)
PA-17-089 See Related NIA 12/16/2016 05/16/2017 05/08/2020 R21 Exploratory Analyses of Existing Cohorts, Data Sets, and Stored Biospecimens to Address Clinical Aging Research Questions (R21)
PA-17-088 See Related NIA 12/16/2016 05/05/2017 05/08/2020 R01 Secondary Analyses of Existing Cohorts, Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01)
PAR-17-066 See Related NIA 12/02/2016 03/05/2017 09/06/2019 R41/R42 Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R41/R42)
PAR-17-067 See Related NIA 12/02/2016 03/05/2017 09/06/2019 R43/R44 Tools for Clinical Care and Management of Alzheimers Disease (AD) and its Comorbidities (R43/R44)
PAR-17-054 See Related NIA 11/16/2016 01/05/2017 05/08/2020 R01 Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimers Disease and Related Dementias (R01)
PAR-17-052 See Related NIA 11/07/2016 01/12/2017 01/08/2020 K18 Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)
PAR-17-039 See Related NIA 10/27/2016 01/16/2017 01/08/2020 R21 Comparative Biology of Neurodegeneration (R21)
PAR-17-033 See Related NIA 10/25/2016 01/05/2017 01/08/2020 R01 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
PAR-17-032 See Related NIA 10/25/2016 01/05/2017 01/08/2020 R01 Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)
PAR-17-031 See Related NIA 10/25/2016 01/05/2017 05/08/2020 R01 Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)
PAR-17-029 See Related NIA 10/21/2016 01/05/2017 11/06/2019 R01 Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01)
PAS-17-026 See Related NIA 10/21/2016 01/16/2017 01/08/2020 R03 Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)
PAR-17-025 See Related NIA 10/20/2016 01/16/2017 01/08/2020 R36 Aging Research Dissertation Awards to Increase Diversity (R36)
PAR-17-024 See Related NIA 10/20/2016 12/25/2016 01/26/2020 U19 Limited Competition: Renewal of the Longevity Consortium (U19)
PAR-17-019 See Related NIA 10/19/2016 12/25/2016 01/08/2020 P30 Revision Requests for Active Alzheimer's Disease Core Centers (P30)
PA-16-442 See Related NIA 09/22/2016 01/05/2017 01/08/2020 R01 Changes in Cellular Architecture During Aging (R01)
PAR-16-371 See Related NIA 07/15/2016 09/16/2016 09/08/2019 R21 Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R21)
PAR-16-370 See Related NIA 07/15/2016 09/05/2016 09/08/2019 R01 Phenotypic and Functional Characterization of ApoE2 to Inform Translation Strategies for Aging-Related Conditions (R01)
PA-16-240 See Related NIA 05/09/2016 09/16/2016 09/08/2019 R21 Mechanisms Mediating Osteoarthritis in Aging (R21)
PA-16-239 See Related NIA 05/09/2016 09/05/2016 09/08/2019 R01 Mechanisms Mediating Osteoarthritis in Aging (R01)
PA-16-231 See Related NIA 05/06/2016 09/16/2016 09/08/2019 R21 Non-healing Ulcerative Wounds in Aging (R21)
PA-16-230 See Related NIA 05/06/2016 09/05/2016 09/08/2019 R01 Non-healing Ulcerative Wounds in Aging (R01)
PAR-16-205 See Related NIA 04/19/2016 08/25/2016 09/08/2019 U24 The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS) (U24)
PAR-19-207 See Related NIAAA 03/04/2019 04/25/2019 09/08/2022 R25 Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
PA-18-863 See Related NIAAA 07/19/2018 09/05/2018 09/08/2021 R01 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional)
PA-18-861 See Related NIAAA 07/19/2018 09/05/2018 01/08/2022 R03 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional)
PA-18-862 See Related NIAAA 07/19/2018 09/16/2018 09/08/2021 R21 Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional)
PA-18-785 See Related NIAAA 05/15/2018 08/05/2018 04/06/2021 R41/R42 Wearable Alcohol Biosensors (STTR) (R41/R42- Clinical Trial Optional)
PA-18-786 See Related NIAAA 05/15/2018 08/05/2018 04/06/2021 R43/R44 Wearable Alcohol Biosensors (SBIR) (R43/R44- Clinical Trial Optional)
PA-18-660 See Related NIAAA 02/14/2018 05/05/2018 05/08/2021 R01 Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)
PAR-18-659 See Related NIAAA 02/14/2018 05/16/2018 05/08/2021 R21/R33 Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed)
PA-18-647 See Related NIAAA 02/08/2018 06/01/2018 03/02/2021 Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp Clinical Trial Optional)
PA-18-619 See Related NIAAA 02/02/2018 05/05/2018 05/08/2021 R01 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional)
PA-18-620 See Related NIAAA 02/02/2018 05/16/2018 05/08/2021 R21 Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional)
PAR-18-580 See Related NIAAA 01/12/2018 02/27/2018 12/05/2020 UT2 Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional)
PAR-18-578 See Related NIAAA 01/12/2018 02/27/2018 12/05/2020 U44 Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)
PAS-18-557 See Related NIAAA 01/02/2018 01/05/2018 05/08/2020 R01 Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
PA-18-508 See Related NIAAA 12/19/2017 05/16/2018 01/08/2021 R21 Effects of In Utero Alcohol Exposure on Adult Health and Disease (R21 - Clinical Trial Optional)
PA-18-507 See Related NIAAA 12/19/2017 05/05/2018 01/08/2021 R01 Effects of In Utero Alcohol Exposure on Adult Health and Disease (R01 - Clinical Trial Optional)
PA-18-413 See Related NIAAA 11/27/2017 01/16/2018 05/08/2020 R03 Epidemiology and Prevention in Alcohol Research (R03 - Clinical Trial - Optional)
PA-18-391 See Related NIAAA 11/27/2017 01/16/2018 05/08/2020 R21 Epidemiology and Prevention in Alcohol Research (R21 - Clinical Trial Optional)
PA-18-390 See Related NIAAA 11/27/2017 01/05/2018 05/08/2020 R01 Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional)
PAR-18-203 See Related NIAAA 11/17/2017 01/17/2018 05/08/2020 R21/R33 Leveraging Electronic Health Records for Alcohol Services Research (R21/R33 Clinical Trial Optional)
PAR-18-196 See Related NIAAA 11/01/2017 01/06/2018 05/08/2020 R01 Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional)
PA-17-467 See Related NIAAA 08/23/2017 09/05/2017 09/08/2020 R01 Secondary Analyses of Existing Alcohol Research Data (R01)
PA-17-468 See Related NIAAA 08/23/2017 09/16/2017 09/08/2020 R03 Secondary Analyses of Existing Alcohol Research Data (R03)
PA-17-297 See Related NIAAA 05/25/2017 09/05/2017 09/08/2020 R01 Alcohol-Induced Effects on Tissue Injury and Repair (R01)
PA-17-296 See Related NIAAA 05/25/2017 09/16/2017 09/08/2020 R21 Alcohol-Induced Effects on Tissue Injury and Repair (R21)
PA-17-219 See Related NIAAA 03/13/2017 05/16/2017 09/08/2020 R21 Mechanisms of Alcohol-associated Cancers (R21)
PA-17-220 See Related NIAAA 03/13/2017 05/05/2017 09/08/2020 R01 Mechanisms of Alcohol-associated Cancers (R01)
PA-17-211 See Related NIAAA 03/09/2017 05/08/2017 05/08/2020 R01 Nutrition and Alcohol-Related Health Outcomes (R01)
PA-17-212 See Related NIAAA 03/09/2017 05/16/2017 05/08/2020 R03 Nutrition and Alcohol-Related Health Outcomes (R03)
PA-17-213 See Related NIAAA 03/09/2017 05/16/2017 05/08/2020 R21 Nutrition and Alcohol-Related Health Outcomes (R21)
PAR-17-170 See Related NIAAA 02/21/2017 04/25/2017 05/08/2020 R24 Alcohol Research Resource Awards (R24)
PA-17-134 See Related NIAAA 01/25/2017 05/16/2017 05/08/2020 R03 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
PA-17-132 See Related NIAAA 01/25/2017 05/16/2017 05/08/2020 R21 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)
PA-17-135 See Related NIAAA 01/25/2017 05/05/2017 05/08/2020 R01 Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)
PA-16-395 See Related NIAAA 08/10/2016 09/05/2016 09/08/2019 R01 Secondary Analyses of Alcohol and Chronic Disease (R01)
PA-16-394 See Related NIAAA 08/10/2016 09/16/2016 09/08/2019 R03 Secondary Analyses of Alcohol and Chronic Disease (R03)
PAR-19-296 See Related NIAID 06/07/2019 09/10/2019 10/14/2021 DP2 NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
RFA-AI-19-042 See Related NIAID 05/30/2019 08/16/2019 09/17/2019 U01 Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
RFA-AI-19-043 See Related NIAID 05/30/2019 08/16/2019 09/17/2019 U19 Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
PAR-19-281 See Related NIAID 05/15/2019 08/13/2019 05/14/2022 R34 NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
RFA-AI-19-041 See Related NIAID 05/02/2019 08/05/2019 09/05/2019 U01 HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
RFA-AI-19-044 See Related NIAID 05/02/2019 08/05/2019 09/05/2019 U19 HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)
RFA-AI-19-045 See Related NIAID 05/01/2019 10/18/2019 11/19/2019 UM1 HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required)
RFA-AI-19-030 See Related NIAID 04/12/2019 06/21/2019 07/23/2019 U01 Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01 Clinical Trial Not Allowed)
PAR-19-247 See Related NIAID 04/11/2019 05/18/2019 06/19/2021 R21 Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)
PAR-19-248 See Related NIAID 04/11/2019 05/10/2019 06/11/2021 R01 Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)
PA-19-237 See Related NIAID 04/03/2019 05/16/2019 05/08/2022 R21 Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)
RFA-AI-19-037 See Related NIAID 04/02/2019 07/06/2019 08/07/2019 R01 Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed)
RFA-AI-19-036 See Related NIAID 03/29/2019 06/30/2019 07/31/2019 R01 Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional)
RFA-AI-19-017 See Related NIAID 03/27/2019 06/30/2019 07/31/2019 U24 Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed)
PAR-19-229 See Related NIAID 03/22/2019 09/01/2019 10/02/2019 UH2 Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)
RFA-AI-19-015 See Related NIAID 03/18/2019 06/07/2019 07/09/2019 U01 Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional)
RFA-AI-19-014 See Related NIAID 03/18/2019 06/07/2019 07/09/2019 UM1 Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
RFA-AI-19-023 See Related NIAID 03/15/2019 06/26/2019 07/27/2019 U01 U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (U01 Clinical Trial Optional)
RFA-AI-19-025 See Related NIAID 03/15/2019 06/26/2019 07/27/2019 U01 U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
RFA-AI-19-024 See Related NIAID 03/15/2019 06/26/2019 07/27/2019 R01 U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
RFA-AI-19-022 See Related NIAID 03/15/2019 06/26/2019 07/27/2019 R01 U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS) (R01 Clinical Trial Optional)
RFA-AI-19-028 See Related NIAID 03/05/2019 05/28/2019 06/29/2019 U01 Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
PAR-19-209 See Related NIAID 03/04/2019 04/06/2019 05/07/2021 R01 Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
RFA-AI-19-029 See Related NIAID 03/04/2019 05/28/2019 06/29/2019 U01 Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
RFA-AI-19-006 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-001 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)
RFA-AI-19-005 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-004 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-003 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
RFA-AI-19-002 See Related NIAID 01/24/2019 07/01/2019 08/02/2019 UM1 HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)
PAS-19-097 See Related NIAID 11/29/2018 01/05/2019 01/08/2022 R01 Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)
PA-19-096 See Related NIAID 11/29/2018 01/04/2019 01/08/2022 R01 Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
PA-19-082 See Related NIAID 11/26/2018 01/05/2019 01/08/2022 R01 Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)
PA-19-083 See Related NIAID 11/26/2018 01/16/2019 01/08/2022 R21 Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)
PA-19-081 See Related NIAID 11/26/2018 01/16/2019 01/08/2022 R21 Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)
PA-19-080 See Related NIAID 11/26/2018 01/05/2019 01/08/2022 R01 Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)
PA-19-077 See Related NIAID 11/26/2018 01/05/2019 01/08/2022 R01 Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
PAR-19-079 See Related NIAID 11/26/2018 01/16/2019 01/08/2022 R21 Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
PAR-19-078 See Related NIAID 11/26/2018 01/04/2019 01/08/2022 R01 Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
PA-19-068 See Related NIAID 11/13/2018 01/16/2019 01/08/2022 R21 Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
PA-19-066 See Related NIAID 11/13/2018 01/16/2019 01/08/2022 R21 Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
PA-19-067 See Related NIAID 11/13/2018 01/05/2019 01/08/2022 R01 Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
PA-19-050 See Related NIAID 11/01/2018 12/07/2018 09/08/2021 R21 Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)
PA-19-042 See Related NIAID 11/01/2018 12/07/2018 09/08/2021 R01 Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)
PA-19-020 See Related NIAID 10/05/2018 01/16/2019 01/08/2022 R21 Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
PA-18-926 See Related NIAID 09/18/2018 09/18/2018 04/02/2021 Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)
PAR-18-923 See Related NIAID 09/17/2018 12/14/2018 01/15/2021 R21 Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
PAR-18-895 See Related NIAID 08/08/2018 12/07/2018 01/08/2021 R01 CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
PAR-18-879 See Related NIAID 07/26/2018 11/02/2018 12/04/2020 U01 Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)
PA-18-873 See Related NIAID 07/24/2018 09/05/2018 09/08/2021 R01 Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
PA-18-872 See Related NIAID 07/24/2018 09/16/2018 09/08/2021 R21 Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
PAR-18-860 See Related NIAID 07/19/2018 09/14/2018 10/16/2020 R21 Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
PA-18-859 See Related NIAID 07/18/2018 09/05/2018 09/08/2021 R01 Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)
PA-18-858 See Related NIAID 07/18/2018 09/16/2018 09/08/2021 R21 Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)
RFA-AI-18-022 See Related NIAID 06/28/2018 09/10/2018 10/10/2019 U01 Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)
PAR-18-822 See Related NIAID 06/07/2018 08/04/2018 09/05/2020 R01 Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
PAR-18-781 See Related NIAID 05/11/2018 08/04/2018 09/10/2020 R21 Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)
PAR-18-764 See Related NIAID 04/20/2018 08/07/2018 05/08/2021 R01 Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
PA-18-753 See Related NIAID 04/11/2018 08/07/2018 05/08/2021 R01 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)
PA-18-754 See Related NIAID 04/11/2018 08/07/2018 05/08/2021 R21 Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed)
PA-18-724 See Related NIAID 03/28/2018 05/16/2018 05/08/2021 R21 Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed)
PA-18-725 See Related NIAID 03/28/2018 05/05/2018 05/08/2021 R01 Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)
PAR-18-712 See Related NIAID 03/15/2018 05/05/2018 05/08/2021 R01 Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
PAR-18-679 See Related NIAID 02/23/2018 05/12/2018 05/08/2020 K99/R00 NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)
PAR-18-633 See Related NIAID 02/06/2018 04/14/2018 01/14/2021 U01 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
PAR-18-632 See Related NIAID 02/06/2018 04/14/2018 01/14/2021 U44 NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
PAR-18-630 See Related NIAID 02/05/2018 03/10/2018 12/07/2019 R01 Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
PA-18-525 See Related NIAID 12/19/2017 03/05/2018 01/06/2021 R43/R44 Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)
PAR-18-411 See Related NIAID 11/16/2017 02/14/2018 03/14/2020 R01 Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
PAR-18-335 See Related NIAID 10/31/2017 06/30/2018 08/01/2020 G11 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed)
PAR-18-319 See Related NIAID 10/13/2017 02/13/2018 03/14/2020 P01 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
PAR-17-471 See Related NIAID 08/25/2017 11/06/2017 12/07/2019 R61/R33 Detection of HIV for Self-Testing (R61/R33)
PAR-17-455 See Related NIAID 08/11/2017 11/06/2017 12/06/2019 R25 NIAID Research Education Program (R25)
PAR-17-439 See Related NIAID 07/28/2017 09/16/2017 09/08/2020 R03 Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03)
PAR-17-332 See Related NIAID 07/21/2017 09/16/2017 07/17/2019 R03 Small Grants on Primary Immunodeficiency Diseases (R03)
PAR-17-333 See Related NIAID 07/21/2017 09/16/2017 07/17/2019 R21 Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)
PAR-17-329 See Related NIAID 07/20/2017 08/07/2017 05/08/2020 K99/R00 NIAID Physician-Scientist Pathway to Independence Award (K99/R00)
PA-17-306 See Related NIAID 06/07/2017 08/07/2017 05/08/2020 R21 Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)
PA-17-305 See Related NIAID 06/06/2017 08/07/2017 05/08/2020 R01 Imaging the Persistent HIV Reservoir (R01)
PA-17-282 See Related NIAID 05/12/2017 08/07/2017 09/08/2020 R21 Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
PA-17-283 See Related NIAID 05/12/2017 08/07/2017 09/08/2020 R01 Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
PAR-17-263 See Related NIAID 04/25/2017 07/01/2017 08/02/2019 R01 Innovation for HIV Vaccine Discovery (R01)
PAR-17-237 See Related NIAID 03/30/2017 07/01/2017 08/18/2019 P30 Centers for AIDS Research (P30)
PAR-17-238 See Related NIAID 03/30/2017 07/01/2017 08/18/2019 P30 Developmental Centers for AIDS Research (P30)
PAR-17-142 See Related NIAID 01/30/2017 04/22/2017 08/23/2019 R01 International Research in Infectious Diseases, including AIDS (R01)
PA-17-114 See Related NIAID 01/09/2017 04/07/2017 01/08/2020 R01 NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
PA-17-113 See Related NIAID 01/09/2017 04/07/2017 01/08/2020 R01 Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
PAR-16-434 See Related NIAID 09/16/2016 09/24/2016 09/08/2019 K22 NIAID Career Transition Award (K22)
PAR-16-413 See Related NIAID 08/18/2016 08/25/2016 01/08/2020 P01 NIAID Investigator Initiated Program Project Applications (P01)
PAR-16-412 See Related NIAID 08/18/2016 08/25/2016 09/08/2019 R24 NIAID Resource-Related Research Projects (R24)
PA-16-244 See Related NIAID 05/09/2016 09/16/2016 09/08/2019 R21 Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21)
PA-16-243 See Related NIAID 05/09/2016 09/05/2016 09/08/2019 R01 Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01)
RFA-AR-20-003 See Related NIAMS 04/26/2019 06/10/2019 07/11/2019 R43 Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43 - Clinical Trial Not Allowed)
RFA-AR-20-001 See Related NIAMS 04/26/2019 07/05/2019 12/02/2020 R01 Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
RFA-AR-20-002 See Related NIAMS 04/26/2019 07/05/2019 12/02/2020 R21 Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
PAR-19-257 See Related NIAMS 04/17/2019 05/19/2019 02/23/2022 R03 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
PA-18-914 See Related NIAMS 09/07/2018 10/05/2018 04/06/2021 Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed
PAR-18-900 See Related NIAMS 08/10/2018 09/04/2018 07/04/2019 X02 Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases (X02 Clinical Trial Not Allowed)
PAR-18-899 See Related NIAMS 08/10/2018 09/04/2018 07/04/2019 X02 Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed)
RFA-AR-19-012 See Related NIAMS 07/23/2018 03/09/2019 01/10/2020 R61/R33 Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
RFA-AR-19-013 See Related NIAMS 07/20/2018 03/09/2019 01/10/2020 R61/R33 Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
PA-18-718 See Related NIAMS 03/28/2018 09/16/2018 09/08/2021 R21 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed)
PA-18-719 See Related NIAMS 03/28/2018 09/05/2018 09/08/2021 R01 Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed)
PAR-18-597 See Related NIAMS 01/29/2018 06/02/2018 11/04/2020 R01 Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
PAR-18-595 See Related NIAMS 01/26/2018 02/27/2018 11/04/2020 R21 Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)
PAR-18-594 See Related NIAMS 01/26/2018 02/27/2018 11/04/2020 U01 NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
PA-18-408 See Related NIAMS 10/26/2017 01/16/2018 05/08/2021 R21 Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed
PA-18-409 See Related NIAMS 10/26/2017 01/05/2018 05/08/2021 R01 Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed
PAR-16-446 See Related NIAMS 09/23/2016 02/01/2017 11/02/2019 R34 NIAMS Clinical Trial Planning Grant (R34)
PAR-19-215 See Related NIBIB 03/08/2019 04/30/2019 05/29/2021 R25 Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
PAR-19-156 See Related NIBIB 01/08/2019 01/08/2019 01/08/2022 U01 Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)
PAR-19-157 See Related NIBIB 01/08/2019 01/08/2019 01/08/2022 U01 Bioengineering Research Partnerships (U01 Clinical Trial Required)
PAR-19-158 See Related NIBIB 01/08/2019 01/08/2019 01/08/2022 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
PAR-19-159 See Related NIBIB 01/08/2019 01/08/2019 05/08/2021 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)
RFA-EB-18-003 See Related NIBIB 12/10/2018 01/08/2019 02/23/2021 U18 HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
PA-18-680 See Related NIBIB 02/23/2018 02/23/2018 03/18/2020 Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp Clilnical Trial Not Allowed)
PA-18-631 See Related NIBIB 02/05/2018 03/05/2018 01/06/2021 R44 NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required)
PAR-18-433 See Related NIBIB 12/15/2017 01/25/2018 01/08/2021 R21 NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)
PAR-18-434 See Related NIBIB 12/15/2017 01/05/2018 09/08/2020 R01 Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)
PA-18-418 See Related NIBIB 11/30/2017 01/05/2018 01/08/2021 R01 NIBIB Research Project Grant (R01 Clinical Trial Required)
PAR-18-207 See Related NIBIB 11/17/2017 01/17/2018 09/08/2019 R21 NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
PAR-18-205 See Related NIBIB 10/30/2017 12/26/2017 01/08/2020 P41 NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)
RFA-EB-17-005 See Related NIBIB 10/12/2017 11/15/2017 09/04/2019 R01 BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
RFA-HD-20-012 See Related NICHD 05/08/2019 06/30/2019 08/01/2019 R13 Pediatric Critical Care Conferences Initiative (R13 Clinical Trial Not Allowed)
PAR-19-263 See Related NICHD 05/01/2019 06/01/2019 05/02/2020 X01 Biological Testing Facility Access For Contraceptive Development (X01 Clinical Trial Not Allowed)
PAR-19-261 See Related NICHD 04/26/2019 06/01/2019 12/14/2021 X01 Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
RFA-HD-20-005 See Related NICHD 03/18/2019 05/27/2019 06/28/2019 R01 Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
RFA-HD-20-004 See Related NICHD 03/13/2019 03/19/2019 06/28/2019 P2C Medical Rehabilitation Research Resource (P2C Clinical Trial Optional)
PAR-19-133 See Related NICHD 12/21/2018 01/25/2019 01/08/2021 R15 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
PAR-19-069 See Related NICHD 11/16/2018 01/16/2019 09/08/2019 R03 Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
PAR-18-951 See Related NICHD 10/05/2018 03/15/2019 04/16/2021 U01 Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)
PAR-18-950 See Related NICHD 10/05/2018 11/11/2018 12/12/2020 X02 Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)
PAR-18-885 See Related NICHD 08/01/2018 11/04/2018 12/05/2020 R21 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
PAR-18-884 See Related NICHD 08/01/2018 11/04/2018 12/05/2020 R01 Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
PAR-18-853 See Related NICHD 07/10/2018 10/27/2018 11/28/2020 R61/R33 Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
PA-18-838 See Related NICHD 06/26/2018 09/05/2018 09/08/2021 R01 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
PA-18-839 See Related NICHD 06/26/2018 09/16/2018 09/08/2021 R21 Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
PAR-18-831 See Related NICHD 06/14/2018 10/07/2018 06/04/2021 R21 The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
PAR-18-830 See Related NICHD 06/14/2018 10/07/2018 06/04/2021 R01 The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
PA-18-791 See Related NICHD 05/21/2018 09/16/2018 09/08/2021 R03 Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical Trial Optional)
PA-18-790 See Related NICHD 05/21/2018 09/05/2018 09/08/2021 R01 Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical Trial Optional)
PAR-18-766 See Related NICHD 04/27/2018 09/05/2018 09/08/2021 R01 Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional)
PAR-18-734 See Related NICHD 03/30/2018 05/16/2018 09/08/2019 R03 Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 - Clinical Trial Not Allowed)
PA-18-729 See Related NICHD 03/28/2018 05/05/2018 01/08/2021 R01 Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
PA-18-728 See Related NICHD 03/28/2018 05/16/2018 01/08/2021 R21 Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
PA-18-687 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R03 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional)
PA-18-688 See Related NICHD 03/01/2018 05/05/2018 05/08/2021 R01 Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional)
PAR-18-689 See Related NICHD 03/01/2018 05/05/2018 05/08/2021 R01 Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional)
PAR-18-690 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R03 Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional)
PAR-18-691 See Related NICHD 03/01/2018 05/16/2018 05/08/2021 R21 Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional)
PAR-18-511 See Related NICHD 12/19/2017 01/05/2018 01/08/2021 R01 Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional)
PAR-18-506 See Related NICHD 12/18/2017 05/05/2018 05/08/2021 R01 Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional)
PA-18-485 See Related NICHD 12/11/2017 01/05/2018 01/08/2021 R01 Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)
PA-18-491 See Related NICHD 12/11/2017 01/16/2018 01/08/2021 R03 Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)
PA-18-482 See Related NICHD 12/06/2017 01/16/2018 01/08/2021 R21 NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional)
PA-18-480 See Related NICHD 12/06/2017 01/05/2018 01/08/2021 R01 NICHD Research Project Grant (R01 - Clinical Trial Required)
PA-18-481 See Related NICHD 12/05/2017 01/16/2018 01/08/2021 R03 NICHD Small Grant Program (R03 - Clinical Trial Optional)
PAR-18-215 See Related NICHD 11/28/2017 03/05/2018 04/04/2020 R01 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
PAR-18-214 See Related NICHD 11/28/2017 03/05/2018 04/04/2020 R21 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
PA-18-049 See Related NICHD 11/15/2017 01/17/2018 05/08/2020 R21 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
PA-18-048 See Related NICHD 11/15/2017 01/17/2018 01/08/2020 R21 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
PA-18-047 See Related NICHD 11/15/2017 01/17/2018 01/08/2020 R21 Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
PA-18-046 See Related NICHD 11/03/2017 01/17/2018 09/08/2019 R03 Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional)
PA-18-045 See Related NICHD 11/03/2017 01/17/2018 09/08/2019 R21 Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional)
PA-18-044 See Related NICHD 11/03/2017 01/17/2018 01/08/2020 R03 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)
PA-18-043 See Related NICHD 11/03/2017 01/17/2018 01/08/2020 R21 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
PA-18-038 See Related NICHD 11/03/2017 01/06/2018 01/08/2020 R01 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional)
PA-18-033 See Related NICHD 11/03/2017 01/06/2018 09/08/2019 R01 Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional)
PA-18-092 See Related NICHD 11/02/2017 01/17/2018 09/08/2019 R21 Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional)
PA-18-031 See Related NICHD 11/02/2017 01/06/2018 09/08/2019 R01 Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional)
PAR-18-333 See Related NICHD 10/25/2017 03/04/2018 12/06/2019 R01 Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)
PAR-17-454 See Related NICHD 08/08/2017 11/06/2017 12/07/2019 R01 Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
PA-17-452 See Related NICHD 08/03/2017 09/05/2017 09/08/2020 R01 Pregnancy in Women with Disabilities (R01)
PA-17-451 See Related NICHD 08/03/2017 09/16/2017 09/08/2020 R03 Pregnancy in Women with Disabilities (R03)
PA-17-299 See Related NICHD 05/26/2017 09/16/2017 05/08/2020 R03 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
PA-17-262 See Related NICHD 04/25/2017 09/05/2017 09/08/2020 R01 Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
PAR-17-236 See Related NICHD 03/29/2017 05/05/2017 11/06/2019 R01 Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)
PAR-17-199 See Related NICHD 03/29/2017 08/05/2017 01/06/2020 R43 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)
PAR-17-200 See Related NICHD 03/29/2017 08/05/2017 01/06/2020 R41 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)
PAR-17-192 See Related NICHD 03/29/2017 05/16/2017 05/08/2020 R21 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)
PAR-17-191 See Related NICHD 03/29/2017 05/16/2017 05/08/2020 R03 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03)
PAR-17-193 See Related NICHD 03/29/2017 05/05/2017 05/08/2020 R01 Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)
PAR-17-228 See Related NICHD 03/21/2017 05/19/2017 10/24/2019 R24 Resource-Related Research Projects in the Epidemiology and Prevention of Pediatric Injury (R24)
PAR-17-188 See Related NICHD 03/03/2017 07/07/2017 04/04/2020 R03 Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
PAR-17-169 See Related NICHD 02/21/2017 05/16/2017 05/08/2020 R21 Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
PA-17-091 See Related NICHD 12/19/2016 05/05/2017 05/08/2020 R01 Fertility Status as a Marker for Overall Health (R01)
PAR-17-005 See Related NICHD 10/07/2016 05/05/2017 11/06/2019 R01 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
PA-16-445 See Related NICHD 09/23/2016 01/05/2017 01/08/2020 R01 Trophoblast Differentiation and Function (R01)
PAR-16-215 See Related NICHD 04/26/2016 05/05/2016 09/08/2019 R01 Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01)
RFA-DA-20-015 See Related NIDA 06/25/2019 09/23/2019 10/24/2019 U01 Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)
RFA-DA-20-008 See Related NIDA 06/25/2019 10/14/2019 11/14/2019 R01 Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)
RFA-DA-20-009 See Related NIDA 06/25/2019 10/14/2019 11/15/2019 R21 Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)
RFA-DA-20-016 See Related NIDA 05/31/2019 07/14/2019 08/15/2019 U01 National Drug Early Warning System Coordinating Center (U01 Clinical Trial Optional )
RFA-DA-20-019 See Related NIDA 05/30/2019 09/17/2019 10/18/2019 R61/R33 Exploiting In Vivo Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments (R61/R33 - Clinical Trial Not Allowed)
RFA-DA-20-001 See Related NIDA 05/22/2019 09/17/2019 10/18/2019 R25 Workshops on the Use of Adolescent Brain Cognitive Development (ABCD) Data (R25 Clinical Trial Not Allowed)
RFA-DA-20-013 See Related NIDA 05/16/2019 10/08/2019 11/09/2019 R01 PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional)
RFA-DA-20-020 See Related NIDA 05/15/2019 07/07/2019 08/08/2019 R41/R42 Rapid Assessment of Drug Abuse: Smart City Tools (R41/R42 - Clinical Trial Optional)
RFA-DA-20-021 See Related NIDA 05/15/2019 07/07/2019 08/08/2019 R43/R44 Rapid Assessment of Drug Abuse: Smart City Tools (R43/R44 - Clinical Trial Optional)
PAR-19-282 See Related NIDA 05/15/2019 09/10/2019 05/08/2023 R61/R33 Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
RFA-DA-20-017 See Related NIDA 05/13/2019 06/29/2019 07/30/2019 R41/R42 Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
RFA-DA-20-018 See Related NIDA 05/13/2019 06/29/2019 07/30/2019 R43/R44 Digital Health Technologies to Address the Social Determinants of Health in context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
PAR-19-278 See Related NIDA 05/08/2019 05/24/2019 12/18/2021 R21/R33 Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
RFA-DA-20-012 See Related NIDA 05/08/2019 06/30/2019 08/01/2019 R43/R44 Blockchain Technology to Improve SUD Care (R43/R44 - Clinical Trial Optional)
RFA-DA-20-011 See Related NIDA 05/08/2019 06/30/2019 08/01/2019 R41/R42 Blockchain Technology to Improve SUD Care (R41/R42 - Clinical Trial Optional)
RFA-DA-20-005 See Related NIDA 04/25/2019 07/15/2019 08/16/2019 U01 Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)
PAR-19-258 See Related NIDA 04/24/2019 06/22/2019 09/08/2021 R25 NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
PAR-19-259 See Related NIDA 04/24/2019 08/25/2019 01/08/2022 P50 NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
PAR-19-246 See Related NIDA 04/10/2019 05/12/2019 09/16/2020 R25 Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)
RFA-DA-20-003 See Related NIDA 04/03/2019 06/24/2019 07/25/2019 U24 Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Data Analysis, Informatics and Resource Center (U24 Clinical Trial Not Allowed)
RFA-DA-20-002 See Related NIDA 04/03/2019 06/24/2019 07/25/2019 U01 Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Linked Research Project Sites (Collaborative U01 Clinical Trial Not Allowed)
RFA-DA-20-004 See Related NIDA 04/03/2019 06/24/2019 07/25/2019 U24 Limited Competition for Adolescent Brain Cognitive Development (ABCD) Study - Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-DA-19-037 See Related NIDA 04/01/2019 04/08/2019 10/09/2019 UM1 Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed)
PAR-19-223 See Related NIDA 03/18/2019 09/21/2019 10/20/2021 DP1 Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
PAR-19-212 See Related NIDA 03/07/2019 06/23/2019 03/24/2022 R01 Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
PAR-19-213 See Related NIDA 03/07/2019 06/23/2019 03/24/2022 R34 Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
PAR-19-162 See Related NIDA 01/09/2019 05/05/2019 09/08/2021 R01 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
PAR-19-163 See Related NIDA 01/09/2019 05/16/2019 09/08/2021 R21 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
RFA-DA-19-019 See Related NIDA 12/10/2018 12/10/2018 09/09/2021 R43/R44 HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
RFA-DA-19-020 See Related NIDA 12/10/2018 12/10/2018 09/09/2021 R41/R42 HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional)
PAR-19-064 See Related NIDA 11/09/2018 01/08/2019 11/09/2021 R21 Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
PAR-18-918 See Related NIDA 09/10/2018 09/16/2018 09/08/2021 R03 Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
PA-18-917 See Related NIDA 09/10/2018 09/24/2018 09/08/2021 R01 Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)
PA-18-916 See Related NIDA 09/10/2018 12/07/2018 09/08/2021 R03 AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
PAS-18-915 See Related NIDA 09/10/2018 12/07/2018 09/08/2021 R01 HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
PAR-18-789 See Related NIDA 05/16/2018 07/21/2018 03/20/2021 U01 Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed)
PA-18-780 See Related NIDA 05/10/2018 08/07/2018 05/08/2021 R34 Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional)
PA-18-773 See Related NIDA 05/09/2018 05/09/2018 05/08/2021 R01 International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)
PA-18-775 See Related NIDA 05/09/2018 05/16/2018 01/08/2021 R34 Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)
PA-18-774 See Related NIDA 05/09/2018 05/16/2018 05/08/2021 R34 Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
PAR-18-746 See Related NIDA 04/06/2018 05/11/2018 08/29/2020 K12 NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
PAR-18-742 See Related NIDA 04/03/2018 06/17/2018 02/12/2021 R61/R33 Exploring Epigenomic or Non-Coding RNA Regulation in the Development, Maintenance, or Treatment of Chronic Pain (R61/R33 Clinical Trial Optional)
RFA-DA-18-022 See Related NIDA 03/14/2018 07/22/2018 08/22/2020 R01 Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
RFA-DA-19-003 See Related NIDA 02/15/2018 06/17/2018 07/18/2020 R61/R33 Exploiting Omics Assays to Investigate Molecular Regulation of Persistent HIV in Individuals with Substance Use Disorder (R61/R33 Clinical Trial Optional)
PA-18-634 See Related NIDA 02/06/2018 05/16/2018 05/08/2020 R03 NIDA Small Research Grant Program (R03 Clinical Trial Required)
PAS-18-624 See Related NIDA 02/02/2018 05/05/2018 09/08/2020 R01 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)
PAS-18-625 See Related NIDA 02/02/2018 05/16/2018 09/08/2020 R21 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)
PA-18-602 See Related NIDA 01/29/2018 05/16/2018 05/08/2021 R21 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional)
PA-18-601 See Related NIDA 01/29/2018 05/16/2018 05/08/2021 R03 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional)
PA-18-603 See Related NIDA 01/29/2018 05/05/2018 05/08/2021 R01 Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional)
PAR-18-437 See Related NIDA 01/09/2018 07/20/2018 02/11/2021 R21 Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)
PAR-18-527 See Related NIDA 12/18/2017 01/16/2018 05/08/2020 R03 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
PAR-18-510 See Related NIDA 12/18/2017 01/08/2018 05/08/2020 R01 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
PAR-18-509 See Related NIDA 12/18/2017 01/16/2018 05/08/2020 R21 Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
PAR-18-494 See Related NIDA 12/15/2017 02/27/2018 07/25/2020 UG3/UH3 Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)
RFA-DA-19-002 See Related NIDA 12/15/2017 01/25/2018 01/02/2020 UG3/UH3 Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)
RFA-DA-18-020 See Related NIDA 12/06/2017 06/25/2018 09/08/2020 UG3/UH3 NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
RFA-DA-18-019 See Related NIDA 12/06/2017 07/14/2018 08/15/2020 DP1 NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
PAR-18-225 See Related NIDA 11/30/2017 08/27/2018 01/08/2020 P30 NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
PAR-18-223 See Related NIDA 11/30/2017 06/17/2018 11/14/2020 R34 Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
PAR-18-222 See Related NIDA 11/30/2017 06/17/2018 11/14/2020 R01 Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)
PAR-18-425 See Related NIDA 11/29/2017 12/25/2017 09/08/2019 P01 NIDA Program Project Grant Applications (P01, Clinical Trial Optional)
PAR-18-219 See Related NIDA 11/21/2017 02/25/2018 07/26/2019 U01 Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
PAR-18-218 See Related NIDA 11/21/2017 02/25/2018 07/26/2019 R01 Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
PAR-18-086 See Related NIDA 11/17/2017 01/17/2018 09/08/2019 R21/R33 Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional)
PAR-18-085 See Related NIDA 11/17/2017 01/17/2018 09/08/2019 R33 Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional)
PAR-18-084 See Related NIDA 11/17/2017 01/17/2018 01/08/2020 R21/R33 Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)
PA-18-080 See Related NIDA 11/03/2017 01/17/2018 05/08/2020 R03 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional)
PA-18-079 See Related NIDA 11/03/2017 01/17/2018 05/08/2020 R21 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional)
PA-18-078 See Related NIDA 11/03/2017 01/17/2018 01/08/2020 R21 Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
PA-18-061 See Related NIDA 11/03/2017 01/06/2018 05/08/2020 R01 Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional)
PA-18-060 See Related NIDA 11/03/2017 01/06/2018 01/08/2020 R01 Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
PAR-18-062 See Related NIDA 11/01/2017 01/06/2018 09/08/2019 R01 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
PAR-17-458 See Related NIDA 08/15/2017 02/01/2018 11/01/2020 X01 Population Assessment of Tobacco and Health (PATH) Biospecimen Access (X01)
PAR-17-242 See Related NIDA 04/04/2017 07/15/2017 03/04/2020 R21 Extracellular Vesicles and Substance Use Disorders (R21)
PAR-17-250 See Related NIDA 04/04/2017 07/15/2017 03/04/2020 R01 Extracellular Vesicles and Substance Use Disorders (R01)
RFA-DA-18-004 See Related NIDA 03/31/2017 10/13/2017 11/14/2019 DP2 Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)
PA-17-157 See Related NIDA 02/08/2017 05/16/2017 05/08/2020 R21 Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
PA-17-155 See Related NIDA 02/08/2017 05/05/2017 05/08/2020 R01 Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
PA-17-119 See Related NIDA 01/10/2017 01/10/2017 01/08/2020 R01 Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
PA-17-120 See Related NIDA 01/10/2017 01/10/2017 01/08/2020 R01 Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
PA-16-443 See Related NIDA 09/22/2016 01/16/2017 01/08/2020 R36 Drug Abuse Dissertation Research (R36)
PAR-16-383 See Related NIDA 08/01/2016 09/16/2016 09/08/2019 R03 Chemistry Science Track Award for Rapid Transition (C/START) (R03)
PAR-16-384 See Related NIDA 08/01/2016 09/16/2016 09/08/2019 R21/R33 Chemical Discovery (CHEM) Award (R21/R33)
PAR-19-143 See Related NIDCD 12/28/2018 01/08/2019 01/08/2021 K18 NIDCD Research Career Enhancement Award for Established Investigators (K18 Basic Experimental Studies with Humans Required)
PAR-19-142 See Related NIDCD 12/28/2018 01/15/2019 01/08/2021 K01 NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
PAR-19-137 See Related NIDCD 12/26/2018 01/07/2019 10/07/2021 P50 NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
PA-19-046 See Related NIDCD 10/31/2018 01/16/2019 01/08/2022 R21 Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional)
PA-19-047 See Related NIDCD 10/31/2018 01/05/2019 01/08/2022 R01 Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional)
RFA-DC-19-001 See Related NIDCD 07/03/2018 09/04/2018 06/05/2021 R21/R33 NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
PAR-18-700 See Related NIDCD 03/14/2018 03/15/2018 01/08/2021 F32 NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed)
PAR-18-436 See Related NIDCD 01/09/2018 01/15/2018 01/08/2021 K01 NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 - No Independent Clinical Trials)
PAR-18-435 See Related NIDCD 01/09/2018 01/15/2018 01/08/2021 K01 NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
PAR-18-562 See Related NIDCD 01/09/2018 01/10/2018 01/08/2021 K18 NIDCD Research Career Enhancement Award for Established Investigators (K18 -Clinical Trials Required)
PAR-18-564 See Related NIDCD 01/09/2018 01/10/2018 01/08/2021 K18 NIDCD Research Career Enhancement Award for Established Investigators (K18 - No Independent Clinical Trials)
PA-18-438 See Related NIDCD 01/09/2018 01/16/2018 11/06/2020 R01 Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional)
PA-18-382 See Related NIDCD 01/09/2018 01/16/2018 11/17/2020 R21 Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional)
PAR-18-533 See Related NIDCD 12/21/2017 05/18/2018 02/23/2021 R01 NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
PAR-18-487 See Related NIDCD 12/11/2017 01/27/2018 10/28/2020 R21 NIDCD Early Career Research(ECR) Award (R21 - Clinical Trials Optional)
PA-18-334 See Related NIDCD 11/13/2017 01/05/2018 01/08/2021 R01 NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required)
PAR-18-340 See Related NIDCD 11/13/2017 01/22/2018 10/22/2020 U01 NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01-Clinical Trial Required)
PA-18-288 See Related NIDCD 11/02/2017 01/17/2018 05/08/2020 R21 Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)
PA-18-287 See Related NIDCD 11/02/2017 01/06/2018 05/08/2020 R01 Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional)
PA-18-328 See Related NIDCD 10/20/2017 01/16/2018 12/17/2020 R21 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R21-Clinical Trial Optional)
PA-18-316 See Related NIDCD 10/20/2017 01/05/2018 12/17/2020 R01 Typical and Atypical Patterns of Language and Literacy in Dual Language Learners (R01-Clinical Trial Optional)
PAR-19-292 See Related NIDCR 06/05/2019 09/05/2019 09/08/2022 R01 Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed)
PAR-19-293 See Related NIDCR 06/05/2019 09/16/2019 09/08/2022 R21 Development of Novel and Robust Systems for Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R21 Clinical Trial Not Allowed)
RFA-DE-20-001 See Related NIDCR 04/08/2019 06/29/2019 07/30/2019 R01 Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)
PAR-19-240 See Related NIDCR 04/04/2019 09/16/2019 09/08/2022 R21 Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed)
PAR-19-239 See Related NIDCR 04/04/2019 09/05/2019 09/07/2022 R01 Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed)
PAR-19-238 See Related NIDCR 04/04/2019 05/12/2019 05/08/2022 K18 Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18 Independent Clinical Trial Not Allowed)
PAR-19-173 See Related NIDCR 01/29/2019 05/16/2019 05/08/2022 R21 Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
PAR-19-172 See Related NIDCR 01/29/2019 05/05/2019 05/08/2022 R01 Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)
PAR-19-160 See Related NIDCR 01/08/2019 01/12/2019 01/08/2022 K01 NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Clinical Trial Not Allowed)
PAR-19-161 See Related NIDCR 01/08/2019 01/12/2019 01/08/2022 K01 NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Basic Experimental Studies with Humans Required)
PAR-19-152 See Related NIDCR 01/08/2019 01/12/2019 01/08/2022 K22 NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
PAR-19-151 See Related NIDCR 01/08/2019 01/12/2019 01/08/2022 K22 NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Basic Experimental Studies with Humans Required)
PAR-19-145 See Related NIDCR 01/08/2019 01/16/2019 01/08/2022 R03 NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
PAR-19-141 See Related NIDCR 12/28/2018 01/12/2019 01/08/2022 K99/R00 NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required)
PAR-19-144 See Related NIDCR 12/28/2018 01/12/2019 01/08/2022 K99/R00 NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
PAR-19-134 See Related NIDCR 12/21/2018 01/25/2019 01/08/2022 R15 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
PA-19-075 See Related NIDCR 11/26/2018 03/05/2019 01/06/2022 R41/R42 Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed)
PA-19-076 See Related NIDCR 11/26/2018 03/05/2019 01/06/2022 R43/R44 Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)
PA-19-034 See Related NIDCR 10/24/2018 12/05/2018 09/06/2021 R43/R44 Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)
PA-19-033 See Related NIDCR 10/24/2018 12/05/2018 09/06/2021 R41/R42 Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)
PA-19-021 See Related NIDCR 10/09/2018 12/05/2018 09/06/2021 R41/R42 Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42 Clinical Trial Not Allowed)
PA-19-022 See Related NIDCR 10/09/2018 12/05/2018 09/06/2021 R43/R44 Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R43/R44 Clinical Trial Not Allowed)
PA-18-876 See Related NIDCR 07/25/2018 09/05/2018 09/08/2021 R01 Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
PA-18-874 See Related NIDCR 07/25/2018 09/16/2018 09/08/2021 R21 Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)
PAR-18-875 See Related NIDCR 07/25/2018 09/05/2018 09/08/2021 R01 Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed)
PAR-18-788 See Related NIDCR 05/16/2018 09/16/2018 09/08/2021 R21 Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed)
PAR-18-787 See Related NIDCR 05/16/2018 09/05/2018 09/08/2021 R01 Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)
PA-18-695 See Related NIDCR 03/05/2018 04/07/2018 01/08/2021 R21 Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed)
PA-18-699 See Related NIDCR 03/05/2018 04/07/2018 01/08/2021 R01 Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed)
PAR-18-656 See Related NIDCR 02/13/2018 05/07/2018 01/08/2021 UG3/UH3 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
PAR-18-547 See Related NIDCR 12/21/2017 01/23/2018 01/08/2021 UG3/UH3 NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3) - Clinical Trial Required
PAR-18-432 See Related NIDCR 12/15/2017 01/12/2018 01/08/2021 K99/R00 NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)
PAR-18-360 See Related NIDCR 11/15/2017 01/12/2018 01/08/2021 K22 NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required)
PAR-18-359 See Related NIDCR 11/15/2017 01/12/2018 01/08/2021 K01 NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required)
PAR-17-154 See Related NIDCR 02/03/2017 03/14/2017 01/08/2020 U01 NIDCR Prospective Observational or Biomarker Clinical Validation Study Cooperative Agreement (U01)
PAR-16-409 See Related NIDCR 08/16/2016 09/16/2016 09/08/2019 R03 NIDCR Small Grant Program for New Investigators (R03)
PAR-16-362 See Related NIDCR 07/11/2016 09/16/2016 09/08/2019 R03 NIDCR Small Research Grants for Secondary Analysis of FaceBase Data (R03)
PA-16-295 See Related NIDCR 05/27/2016 09/05/2016 09/08/2019 R01 Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01)
PA-16-296 See Related NIDCR 05/27/2016 09/16/2016 09/08/2019 R21 Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21)
PAR-19-294 See Related NIDDK 06/06/2019 10/12/2019 11/13/2021 R01 Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
RFA-DK-19-008 See Related NIDDK 05/29/2019 10/07/2019 11/08/2019 R01 Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)
PAS-19-241 See Related NIDDK 04/05/2019 05/05/2019 05/08/2022 R01 Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
RFA-DK-19-003 See Related NIDDK 03/21/2019 06/18/2019 07/19/2019 P30 Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
PAR-19-222 See Related NIDDK 03/18/2019 05/16/2019 05/08/2022 R21 Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
RFA-DK-19-004 See Related NIDDK 03/13/2019 10/01/2019 07/02/2021 P30 Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
RFA-DK-19-002 See Related NIDDK 03/13/2019 09/23/2019 06/03/2020 P30 Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
RFA-DK-19-006 See Related NIDDK 03/11/2019 07/06/2019 08/07/2019 R25 Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed)
PAR-19-202 See Related NIDDK 02/27/2019 04/30/2019 11/03/2021 RC2 High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
RFA-DK-18-024 See Related NIDDK 01/28/2019 03/10/2019 11/21/2019 F99/K00 The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
PAS-19-105 See Related NIDDK 12/17/2018 01/05/2019 01/08/2022 R01 Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
PA-19-065 See Related NIDDK 11/13/2018 01/05/2019 01/08/2022 R01 Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed)
PAR-19-030 See Related NIDDK 10/18/2018 12/25/2018 01/29/2021 R25 NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
PAR-18-924 See Related NIDDK 09/17/2018 10/01/2018 11/02/2019 R34 Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
PAR-18-925 See Related NIDDK 09/17/2018 10/01/2018 11/02/2019 R18 Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
PA-18-903 See Related NIDDK 08/14/2018 09/16/2018 09/08/2021 R21 Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional)
PAR-18-898 See Related NIDDK 08/09/2018 10/01/2018 06/02/2021 RC2 Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
PA-18-891 See Related NIDDK 08/07/2018 10/01/2018 06/02/2021 RC2 Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
PAR-18-886 See Related NIDDK 08/02/2018 10/01/2018 06/02/2021 RC2 New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
PAR-18-857 See Related NIDDK 07/17/2018 09/16/2018 09/08/2021 R21 Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
PA-18-856 See Related NIDDK 07/17/2018 09/05/2018 09/08/2021 R01 Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
PAR-18-854 See Related NIDDK 07/12/2018 07/23/2018 09/11/2021 R01 Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
PAR-18-743 See Related NIDDK 04/04/2018 05/16/2018 05/08/2021 R21 Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
PAR-18-744 See Related NIDDK 04/04/2018 05/16/2018 05/08/2021 R21 Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
PA-18-741 See Related NIDDK 04/03/2018 05/16/2018 05/08/2021 R21 Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
PAR-18-727 See Related NIDDK 03/29/2018 05/11/2018 09/28/2019 R01 Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
PAS-18-730 See Related NIDDK 03/29/2018 05/05/2018 05/08/2021 R01 New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
PA-18-720 See Related NIDDK 03/27/2018 05/16/2018 05/08/2021 R21 Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
PAS-18-698 See Related NIDDK 03/05/2018 04/07/2018 01/08/2021 R01 High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)